1. Home
  2. VRDN vs HPK Comparison

VRDN vs HPK Comparison

Compare VRDN & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • HPK
  • Stock Information
  • Founded
  • VRDN 2006
  • HPK 2019
  • Country
  • VRDN United States
  • HPK United States
  • Employees
  • VRDN N/A
  • HPK N/A
  • Industry
  • VRDN Medical Specialities
  • HPK Oil & Gas Production
  • Sector
  • VRDN Health Care
  • HPK Energy
  • Exchange
  • VRDN Nasdaq
  • HPK Nasdaq
  • Market Cap
  • VRDN 1.0B
  • HPK 1.1B
  • IPO Year
  • VRDN N/A
  • HPK N/A
  • Fundamental
  • Price
  • VRDN $14.16
  • HPK $10.07
  • Analyst Decision
  • VRDN Strong Buy
  • HPK Sell
  • Analyst Count
  • VRDN 12
  • HPK 2
  • Target Price
  • VRDN $38.50
  • HPK $11.50
  • AVG Volume (30 Days)
  • VRDN 838.2K
  • HPK 352.6K
  • Earning Date
  • VRDN 05-06-2025
  • HPK 05-12-2025
  • Dividend Yield
  • VRDN N/A
  • HPK 1.62%
  • EPS Growth
  • VRDN N/A
  • HPK N/A
  • EPS
  • VRDN N/A
  • HPK 0.88
  • Revenue
  • VRDN $302,000.00
  • HPK $1,039,098,000.00
  • Revenue This Year
  • VRDN N/A
  • HPK N/A
  • Revenue Next Year
  • VRDN $21,976.14
  • HPK N/A
  • P/E Ratio
  • VRDN N/A
  • HPK $11.25
  • Revenue Growth
  • VRDN 4.86
  • HPK N/A
  • 52 Week Low
  • VRDN $9.90
  • HPK $7.82
  • 52 Week High
  • VRDN $27.20
  • HPK $17.48
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 55.33
  • HPK 56.82
  • Support Level
  • VRDN $13.37
  • HPK $9.71
  • Resistance Level
  • VRDN $14.18
  • HPK $10.25
  • Average True Range (ATR)
  • VRDN 0.67
  • HPK 0.41
  • MACD
  • VRDN 0.12
  • HPK 0.12
  • Stochastic Oscillator
  • VRDN 71.43
  • HPK 65.80

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About HPK HighPeak Energy Inc.

HighPeak Energy Inc is an independent crude oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S.

Share on Social Networks: